Skip to main content

Continuous Infusion of Factor Concentrates in Children with Hemophilia A in Comparison to Bolus Injections

  • Conference paper
35th Hemophilia Symposium
  • 346 Accesses

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 129.00
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Brinkhous KM (1954) Hemophilia. Bull N Y Acad Med 30: 325

    PubMed  CAS  Google Scholar 

  2. Campbell PJ, Rickard KA (1998) Continuous and intermittent infusion of coagulation factor concentrates in patients undergoing surgery: a single centre Australian experience. Aust N Z J Med 28(4): 440–5

    PubMed  CAS  Google Scholar 

  3. Hathaway WE, Christian MJ, Clarke SL, Hasiba U (1984) Comparison of continuous and intermittent Factor VIII concentrate therapy in hemophilia A. Am J Hematol 17(1): 85–8

    PubMed  CAS  Google Scholar 

  4. Hay CR, Doughty HI, Savidge GF (1996) Continuous infusion of factor VIII for surgery and major bleeding. Blood Coagul Fibrinolysis 7 Suppl 1: S15–9

    PubMed  CAS  Google Scholar 

  5. Hermens WTH. Dose calculation of human factor VIII and factor IX concentrates for infusion therapy. In: Brinkhous KM, Hemker HC, editors. Handbook of Hemophilia. New York: American Elsevier Publishing; 1975. p. 569–589.

    Google Scholar 

  6. Martinowitz U, Schulman S, Gitel S, Horozowski H, Heim M, Varon D (1992) Adjusted dose continuous infusion of factor VIII in patients with haemophilia A. Br J Haematol 82(4): 729–34

    PubMed  CAS  Google Scholar 

  7. Mulcahy R, Walsh M, Scully MF (2005) Retrospective audit of a continuous infusion protocol for haemophilia A at a single haemophilia treatment centre. Haemophilia 11: 208–215

    Article  PubMed  CAS  Google Scholar 

  8. Schulman S (2003) Continuous infusion. Haemophilia 9(4): 368–75

    Article  PubMed  CAS  Google Scholar 

  9. Schulman S, Gitel S, Martinowitz U (1994) Stability of factor VIII concentrates after reconstitution. Am J Hematol 45(3): 217–23

    PubMed  CAS  Google Scholar 

  10. Schulman S, Varon D, Keller N, Gitel S, Martinowitz U (1994) Monoclonal purified FVIII for continuous infusion: stability, microbiological safety and clinical experience. Thromb Haemost 72(3): 403–7

    PubMed  CAS  Google Scholar 

  11. Sharathkumar A, Lillicrap D, Blanchette VS, Kern M, Leggo J, Stain AM, Brooker L, Carcao MD (2003) Intensive exposure to factor VIII is a risk factor for inhibitor development in mild hemophilia A. J Thromb Haemost 1(6): 1228–36

    Article  PubMed  CAS  Google Scholar 

Download references

Authors

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2006 Springer Verlag Berlin Heidelberg

About this paper

Cite this paper

Bidlingmaier, C., Deml, M., Kurnik, K. (2006). Continuous Infusion of Factor Concentrates in Children with Hemophilia A in Comparison to Bolus Injections. In: Scharrer, I., Schramm, W. (eds) 35th Hemophilia Symposium. Springer, Berlin, Heidelberg. https://doi.org/10.1007/3-540-28546-6_17

Download citation

  • DOI: https://doi.org/10.1007/3-540-28546-6_17

  • Publisher Name: Springer, Berlin, Heidelberg

  • Print ISBN: 978-3-540-28543-4

  • Online ISBN: 978-3-540-28546-5

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics